Artemisinins induce endoplasmic reticulum stress in acute leukaemia cells in vitro and in vivo.

acute leukaemia artemisinin artesunate endoplasmic reticulum stress

Journal

EJHaem
ISSN: 2688-6146
Titre abrégé: EJHaem
Pays: United States
ID NLM: 101761942

Informations de publication

Date de publication:
Nov 2021
Historique:
received: 11 05 2021
revised: 13 09 2021
accepted: 24 09 2021
entrez: 18 7 2022
pubmed: 19 7 2022
medline: 19 7 2022
Statut: epublish

Résumé

Loss of endoplasmic reticulum (ER) homeostasis leads to ER stress, thus prolonged activation can lead to apoptosis. Herein, artesunate (ART) induced ER stress in leukaemia cells, resulting in eIF2α phosphorylation, activation of transcription factor 4, subsequent CHOP upregulation and XBP1 splicing. Furthermore, in vitro cyclin/CDKs reduction induced G1-phase arrest. An in vivo xenograft model showed a consistent pattern of ART in reducing tumour burden, supporting roles in the UPR pathway, which we speculate could lead to apoptosis by NOXA activation. Moreover, ART were capable of increasing the survival of mice. Taken together, our data indicate that ART may represent an interesting weapon to fight leukaemia.

Identifiants

pubmed: 35845184
doi: 10.1002/jha2.314
pii: JHA2314
pmc: PMC9175883
doi:

Types de publication

Journal Article

Langues

eng

Pagination

818-822

Informations de copyright

© 2021 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Pharmacol Ther. 2020 Dec;216:107650
pubmed: 32758647
Proc Natl Acad Sci U S A. 1997 May 13;94(10):5302-7
pubmed: 9144232
Blood Cancer J. 2018 Feb 9;8(2):15
pubmed: 29426921
Cancer Lett. 2018 Feb 1;414:116-126
pubmed: 29129782
Blood Adv. 2021 Feb 9;5(3):711-724
pubmed: 33560385
Int J Mol Sci. 2021 Jan 09;22(2):
pubmed: 33435371
Nature. 2016 Jan 21;529(7586):326-35
pubmed: 26791723
Oncotarget. 2015 Mar 20;6(8):5582-96
pubmed: 25714024
Cancer Chemother Pharmacol. 2021 Jan;87(1):1-22
pubmed: 33141328
Trends Cancer. 2019 Oct;5(10):604-618
pubmed: 31706508
Cancer Lett. 2008 Jun 18;264(2):309-15
pubmed: 18321638
Cell. 2017 Feb 9;168(4):692-706
pubmed: 28187289
Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2200-5
pubmed: 19164757
Semin Cancer Biol. 2017 Oct;46:65-83
pubmed: 28254675
Int J Cell Biol. 2012;2012:735206
pubmed: 22701485
FEBS J. 2020 Jan;287(1):27-42
pubmed: 31647176
Mol Biol Cell. 2013 Aug;24(15):2477-90
pubmed: 23761072

Auteurs

Rubia Isler Mancuso (RI)

Haematology and Transfusion Medicine Center University of Campinas Campinas Brazil.

Juliana Hofstätter Azambuja (JH)

Haematology and Transfusion Medicine Center University of Campinas Campinas Brazil.

Fernanda Soares Niemann (FS)

Haematology and Transfusion Medicine Center University of Campinas Campinas Brazil.

Ada Congrains (A)

Haematology and Transfusion Medicine Center University of Campinas Campinas Brazil.

Mary Ann Foglio (MA)

Faculty of Pharmaceutical Science University of Campinas Campinas Brazil.

Eduardo Magalhães Rego (EM)

Center for Cell Based Therapy University of São Paulo Ribeirão Preto Brazil.
Haematology Division, LIM31, Faculdade de Medicina University of São Paulo São Paulo Brazil.

Sara Teresinha Olalla Saad (ST)

Haematology and Transfusion Medicine Center University of Campinas Campinas Brazil.

Classifications MeSH